RESUMO

Introducción: La semaglutida es un fármaco que contribuye a la liberación de insulina por el páncreas y a la supresión del apetito por lo que lo convierte en un importante candidato para ser usado en el tratamiento de la diabesidad. Objetivo: Describir el efecto de la semaglutida en el tratamiento de las personas con diabesidad. Métodos: Se revisó la literatura publicada en el período comprendido de enero-febrero de 2021. Las palabras clave utilizadas fueron obesidad; diabetes mellitus; diabesidad; semaglutida; análogo del péptido similar al glucagón tipo 1. Se utilizaron como motores de búsqueda las bases de datos de Google Académico, PubMed y SciELO. Se evaluaron diferentes trabajos de revisión, investigación y páginas web que tenían menos de 10 años de publicados en idioma español, portugués o inglés, y que por el título trataban el tema de estudio. Fueron excluidos los artículos que no abordaron la relación entre diabetes y obesidad, así como el tratamiento con análogos del péptido similar al glucagón tipo 1. Esto permitió la consulta de 84 artículos, de los cuales 59 fueron referenciados. Conclusiones: El empleo de semaglutida favorece una mejor evolución en paciente con diabesidad, como complemento de una dieta y una actividad física adecuada. Al optimizar el control glucémico, contribuir a la pérdida de peso y a la mejoraría de ciertas comorbilidades, entre ellas la salud cardiovascular(AU)

Introduction: Semaglutide is a drug that contributes to the release of insulin from the pancreas and suppresses appetite, which makes it an important candidate for treating diabesity. Objective: To describe the role of semaglutide in the treatment of diabesity individuals. Methods: The necessary information to write this article was obtained in the 2022 two-month period January-February. The keywords used were obesity; Mellitus diabetes; diabesity; semaglutide; type 1 glucagon-like peptide analogue. The search engines corresponding to the Google Scholar, PubMed and SciElO databases were used. Different review, research and web pages were evaluated, which in general were published no more than 10 years ago, in Spanish, Portuguese or English and which dealt with the subject of study by title. Articles that did not address the relationship between diabetes and obesity, as well as treatment with glucagon-like peptide 1 analogues, were excluded. This allowed the consultation of 84 articles, 59 of them were referenced. Conclusions: The use of semaglutide, as a complement to a diet and physical activity appropriate to the needs of patients with diabesity, brought about several effects that favor better evolution of this health problem, by optimizing glycemic control, contributing to the loss of weight and the improvement of certain comorbidities, including cardiovascular health(AU)

Assuntos

RESUMO

ABSTRACT Introduction: Diabesity is characterized as a simultaneous condition of type 02 diabetes and obesity. Among the aspects that influence the development of diabetes, the time in sedentary behavior and the time of physical activity are important risk factors. Objectives: To estimate cut-off points for time spent in sedentary behavior and physical activity as a discriminator of the presence of diabesity and to evaluate the predictive ability of WC and PA to identify this condition in quilombola adults. Methodology: this is a cross-sectional study with a sample composed of 332 adults (age ≥ 50 years), participants in the study of the Epidemiological Profile of Quilombolas from Bahia living in the micro-region of Guanambi, Brazil. The data were obtained by means of interviews and anthropometric evaluation. Sociodemographic and lifestyle information (physical activity and sedentary behavior) were included. To analyze the cut-off point of Sedentary Behavior as a predictor of diabesity, the Receiver Operating Characteristic (ROC) curve was used. Results: Time in sedentary behavior >120 min/day and time in physical activity <240 min/week were the best cut-off points for discriminating diabesity in quilombola, with area under the ROC curve of 0.62, 95% CI (0.56-0.67) and 0.62 (95% CI: 0.55-0.67), respectively. Conclusions: The results showed that time in sedentary behavior and time in physical activity showed a good ability to discriminate the presence of diabesity among quilombola adults.

RESUMO Introdução: A Diabesidade caracteriza-se como uma condição simultânea de diabetes tipo 02 e obesidade. Dentre os aspectos que influenciam o desenvolvimento da diabesidade, o tempo em comportamento sedentário e o tempo de atividade física apresentam-se como importantes fatores de risco. Objetivos: estimar pontos de corte para o tempo em comportamento sedentário e atividade física como discriminador de presença de diabesidade e avaliar a capacidade preditiva do CS e AF para identificar essa condição em adultos quilombolas. Metodologia: trata-se de estudo transversal com amostra composta por 332 adultos (idade ≥ 50 anos), participantes do estudo de Perfil Epidemiológico dos Quilombolas baianos residentes na microrregião de Guanambi, Brasil. Os dados foram obtidos por meio de entrevistas e avaliação antropométrica. Foram incluídas informações sociodemográficas e estilo de vida (atividade física e comportamento sedentário). Para a análise do ponto de corte do Comportamento Sedentário e o tempo de atividade física como preditores de diabesidade, foi utilizada a curva Receiver Opereting Characteristic (ROC). Resultados: Tempo em comportamento sedentário >120 min/dia e tempo de atividade física >240 min/semana foram os melhores pontos de corte para discriminar a diabesidade em quilombola, com área sob a curva ROC de 0,62, IC 95% (0,56-0,67) e 0,62 (IC 95%: 0,55-0,67), respectivamente. Conclusões: Os resultados mostraram que o tempo em comportamento sedentário e atividade física apresentaram uma boa capacidade para discriminar a presença de diabesidade entre adultos quilombolas.

Assuntos

RESUMO

BACKGROUND: Diabetes is a risk factor for dementia and mortality, while obesity later in life is associated with a reduced risk. Their co-occurrence, diabesity, is common, but its association with dementia and mortality is unclear. METHODS: Using data from the Mexican Health and Aging Study, we used multinomial logistic regression to examine the associations of diabetes and body mass index (BMI), and diabesity, in 2012, with cognitive impairment and mortality in 2018, among participants aged ≥60 years with normal cognition at baseline (n = 7,885). RESULTS: Diabetes was associated with cognitive impairment, compared to not having diabetes (RRR=1.83, 95% CI=1.48-2.26). BMI was not associated with cognitive impairment. Regarding mortality, diabetes was associated with an increased risk (RRR=2.28, 95% CI=1.98-2.63) and being overweight or having obesity was associated with a reduced risk (RRR=0.74, 95% CI=0.65-0.86; RRR=0.79, 95% CI= 0.66-0.95). When BMI and diabetes were combined, having diabetes only (RRR=2.01, 95% CI=1.40-2.87), being overweight with diabetes (RRR=1.42, 95% CI=1.02-1.97) or having diabesity (RRR=1.50, 95% CI=1.08-2.06) were associated with cognitive impairment, compared to having a normal BMI without diabetes. Diabetes, regardless of BMI, was associated with an increased risk of mortality, while being overweight or having obesity was associated with a reduced risk of mortality. CONCLUSIONS: With the increase in the prevalence of obesity and diabetes among Mexicans, it is important to understand how these conditions and their co-occurrence impact cognitive impairment and mortality. Among older Mexicans, diabesity is associated with 6-year mortality and cognitive impairment onset, likely driven by the effect of diabetes.

Assuntos

RESUMO

A balanced communication between the mother, placenta and foetus is crucial to reach a successful pregnancy. Several windows of exposure to environmental toxins are present during pregnancy. When the women metabolic status is affected by a disease or environmental toxin, the foetus is impacted and may result in altered development and growth. Gestational diabetes mellitus (GDM) is a disease of pregnancy characterised by abnormal glucose metabolism affecting the mother and foetus. This disease of pregnancy associates with postnatal consequences for the child and the mother. The whole endogenous and exogenous environmental factors is defined as the exposome. Endogenous insults conform to the endo-exposome, and disruptors contained in the immediate environment are the ecto-exposome. Some components of the endo-exposome, such as Selenium, vitamins D and B12, adenosine, and a high-fat diet, and ecto-exposome, such as the heavy metals Arsenic, Mercury, Lead and Copper, and per- and polyfluoroakyl substances, result in adverse pregnancies, including an elevated risk of GDM or gestational diabesity. The impact of the exposome on the human placenta's vascular physiology and function in GDM and gestational diabesity is reviewed.

Assuntos

RESUMO

Gestational diabetes mellitus (GDM) shows a deficiency in the metabolism of D-glucose and other nutrients, thereby negatively affecting the foetoplacental vascular endothelium. Maternal hyperglycaemia and hyperinsulinemia play an important role in the aetiology of GDM. A combination of these and other factors predisposes women to developing GDM with pre-pregnancy normal weight, viz. classic GDM. However, women with GDM and prepregnancy obesity (gestational diabesity, GDty) or overweight (GDMow) show a different metabolic status than women with classic GDM. GDty and GDMow are associated with altered l-arginine/nitric oxide and insulin/adenosine axis signalling in the human foetoplacental microvascular and macrovascular endothelium. These alterations differ from those observed in classic GDM. Here, we have reviewed the consequences of GDty and GDMow in the modulation of foetoplacental endothelial cell function, highlighting studies describing the modulation of intracellular pH homeostasis and the potential implications of NO generation and adenosine signalling in GDty-associated foetal vascular insulin resistance. Moreover, with an increase in the rate of obesity in women of childbearing age worldwide, the prevalence of GDty is expected to increase in the next decades. Therefore, we emphasize that women with GDty and GDMow should be characterized with a different metabolic state from that of women with classic GDM to develop a more specific therapeutic approach for protecting the mother and foetus.

Assuntos

RESUMO

Diabetes mellitus, obesity, and cancer are diseases that in recent years have caused a large number of deaths worldwide, so have been in the front line of biomedical research. On the other hand, obesity is a risk factor for several types of cancer and type 2 diabetes mellitus. The metabolic disorder and global inflammatory environment seen in obese patients is also critical for the treatment of both diabetes mellitus and gliomas. Several molecules are increased in patients with obesity and are considered risk factors in the failure of multimodal therapies for diabetes mellitus and gliomas. These molecules include adenosine, insulin, adenosine deaminases, adenosine kinase, lipids, as well as adenosine receptors, adenosine membrane transporters, and the immune response. The role of adenosine will be explained in depth since it is a nucleoside aberrantly increased in patients with these diseases, is one of the main causes of diabetes mellitus progression and the failure of glioma therapies. In addition, the role of type 2 diabetes mellitus/obesity, i.e., diabesity, and its implication in glioma treatment is discussed.

Assuntos

RESUMO

El empleo de la cirugía metabólica, como tratamiento capaz de revertir o mejorar la diabesidad, ha llamado la atención por las transformaciones inducidas en los pacientes sometidos a esta intervención. Esas transformaciones se tratan de explicar a través de los cambios anatómicos y fisiológicos que la intervención produce. Un mayor conocimiento de las teorías y los mecanismos que garantizan la pérdida de peso y una mejor respuesta metabólica puede contribuir al diseño de estrategias más efectivas. El objetivo es describir las teorías y mecanismos que tratan de explicar los cambios benéficos observados después de una cirugía metabólica en personas con diabesidad. Se utilizó como buscador de información científica Google Académico. Se emplearon como palabras clave: cirugía bariátrica, cirugía metabólica, obesidad, diabetes mellitus tipo 2 y diabesidad. Fueron evaluados artículos de revisión y de investigación en idioma español, portugués o inglés que tenían menos de 10 años de publicados, provenientes de diferentes bases de datos: PubMed, LILACS, Cochrane y SciElo y páginas web en general. Esto permitió el estudio de 110 artículos, de los cuales, 66 fueron referenciados. Los cambios inducidos por la cirugía metabólica y sus resultados en personas con diabesidad se han relacionado con diferentes teorías y mecanismos: teoría del intestino proximal y del intestino distal, por ejemplo. A lo anterior se suman los cambios en la microbiota intestinal y la mayor disponibilidad de ácidos biliares en el íleon. Las diferentes teorías se complementan entre sí y es difícil poder establecer cuál de ellas resulta de mayor utilidad, lo que también depende de la técnica quirúrgica empleada (restrictiva o restrictiva malabsortiva) y de sus mecanismos de acción(AU)

The use of metabolic surgery as a treatment capable of either reverting or improving diabesity has attracted attention due to the transformations induced in patients undergoing such intervention. These transformations have been attributed to the anatomical and physiological changes brought about by the surgery. Enriched knowledge about the theories and mechanisms ensuring weight loss and a better metabolic response may contribute to the design of more effective strategies. The objective is to describe the theories and mechanisms which intend to explain the beneficial changes observed after metabolic surgery in people with diabesity. Scientific information was obtained from the search engine Google Scholar using the key words bariatric surgery, metabolic surgery, obesity, type 2 diabetes mellitus and diabesity. Evaluation was conducted of review and research papers published in Spanish, Portuguese or English in the past 10 years on various databases (PubMed, LILACS, Cochrane, SciELO) and webpages. A total 110 papers were analyzed of which 66 were referenced. Changes induced by metabolic surgery and their results in people with diabesity have been associated to different theories and mechanisms, e.g. the proximal intestine hypothesis and the distal intestine hypothesis. To this are added the changes in the intestinal microbiota and a greater availability of bile acids in the ileum. The different theories complement one another, and it is hard to decide which is the most useful, for it also depends on the surgical technique used (restrictive or malabsorptive restrictive) and its mechanisms of action(AU)

Assuntos

RESUMO

Diabesity is the leading cause of modern, chronic disease. In 2012, diabetes killed 1.2 million people worldwide and its global prevalence exceeded 347 million people, and it is expected that it will increase to 540 million by 2030. Because of this health imperative, it is also linked to increasing obesity. The role of the inflammatory process and oxidative stress in the pathophysiology of these diseases is widely documented. This paper review, using data from major databases, the role of biopeptides with antioxidant and anti-inflammatory activity as a potential aid for the prevention and treatment of diabesity, since the mechanisms of action mentioned directly affect oxidative stress and the characteristic imbalance of the inflammatory process of this disease. Some of these studies have demonstrated beneficial results in relation to oxidative stress and proinflammatory markers. However, the role of biopeptides, in relation to oxidative stress and inflammatory biomarkers, remains unclear and represents a potentially fruitful area for further research in the health area.

Assuntos